All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @ahleesahhh on TikTok · 173s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @ahleesahhh's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So I'm going to make reconstitution really, really simple to follow.
  2. 0:03Okay.
  3. 0:04You have your peptide.
  4. 0:06Let's say this is reta.
  5. 0:08Reta can come in different amounts.
  6. 0:09It can come in 5mg, 10mg, 20, 60, 30.
  7. 0:14It doesn't matter.
  8. 0:16Say for example, this is 10mg of reta.
  9. 0:18Okay.
  10. 0:19It comes in a powdered form.
  11. 0:21You need to also have bacteria static water in order to reconstitute this.
  12. 0:26So you have 10mg.
  13. 0:2810mg is not the strength.
  14. 0:30It is the total amount of product in this vial.
  15. 0:32Okay.
  16. 0:33Don't confuse the numbers with the strength.
  17. 0:35It just means the total amount of product.
  18. 0:39So backwater.
  19. 0:40How much backwater do you need to add into your peptide vial?
  20. 0:45I personally like to.
  21. 0:47For every 10mg of product, I personally like to add 1ml of backwater.
  22. 0:53Personally for me, this just makes the math a lot easier.
  23. 0:56Here some people do 3ml into every vial that they use.
  24. 1:01You can do that.
  25. 1:02Most vials of this size will take 3ml of backwater.
  26. 1:06But that just makes the math a bit messy.
  27. 1:10So you've used the syringe to draw up 1ml of water and you've put it into your peptide.
  28. 1:17At an angle, you are going to release the water in there and then you're going to swell
  29. 1:21gently to mix it.
  30. 1:23Now how do you work out the dosage of how much you are going to take each week?
  31. 1:28That's where you are going to use a calculator.
  32. 1:30This is where it gets quite handy.
  33. 1:33So on a calculator it's quite simple.
  34. 1:35You are going to insert the dose you want to take that week.
  35. 1:38For example, most people when they start out, they might start out on a microdose of
  36. 1:420.5 or 1.
  37. 1:44Let's say it's my first week of taking reta.
  38. 1:46I want to take 1mg.
  39. 1:47Okay.
  40. 1:48Now what is the strength of your peptide?
  41. 1:51So I said that in this vial, I have 10mg of reta.
  42. 1:57So the strength of my peptide is 10mg.
  43. 1:59That is the total that's in there.
  44. 2:02And then how much water am I adding to the peptide?
  45. 2:04I'm adding 1ml.
  46. 2:06Remember we said 1ml of backwater.
  47. 2:07It just makes the math very easy.
  48. 2:10We scroll down.
  49. 2:11As you can see on my insulin syringe, this insulin syringe is a 1ml syringe.
  50. 2:16It's 100 units.
  51. 2:17100 units is equal to 1ml.
  52. 2:20On my insulin syringe, it means that I'm going to be drawing up 10 units.
  53. 2:26If I then decide next week I want to up this dose to 2mg.
  54. 2:31Okay.
  55. 2:32I don't change this because I've already added this to this.
  56. 2:34I don't change this.
  57. 2:36It now shows me next week I need to take 20 units.
  58. 2:39And again, if I up that to 5mg, it means that week I'm taking 50 units.
  59. 2:46Okay.
  60. 2:47So I prefer doing the 1ml to every 10g of product.
  61. 2:51It just makes the math a whole lot easier.

@ahleesahhh's peptide mixing tutorial: is the math right?

Thatgirlahleesah🦋

TikTok creator

142.3K viewsWatch on TikTok

Quick answer

The video demonstrates reconstitution of retatrutide, an investigational tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors, using a 1mg per 10 units on a 100-unit insulin syringe convention. Retatrutide has shown significant weight reduction in Phase 2 trials (Jastreboff et al., 2023, NEJM) but carries no approved dosing protocol, and self-administration guidance from social media bypasses the clinical monitoring these trials required. Compounded retatrutide sourced outside a regulated telehealth pathway has no verified potency, sterility, or safety data.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @ahleesahhh's peptide mixing tutorial: is the math right?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@ahleesahhh's peptide mixing tutorial: is the math right? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@ahleesahhh's peptide mixing tutorial: is the math right?" from Thatgirlahleesah🦋. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video demonstrates reconstitution of retatrutide, an investigational tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors, using a 1mg per 10 units on a 100-unit insulin syringe convention.

The reason this review is not generic is the source wording and the canonical claim label "peptides a little video to help anyone out with their maths reconsti." In this clip, the useful excerpt is: "So I'm going to make reconstitution really, really simple to follow." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Retatrutide is an investigational GLP-1/GIP/glucagon tri-agonist with no FDA or TGA approval.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video demonstrates reconstitution of retatrutide, an investigational tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors, using a 1mg per 10 units on a 100-unit insulin syringe convention.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video demonstrates reconstitution of retatrutide, an investigational tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors, using a 1mg per 10 units on a 100-unit insulin syringe convention. Retatrutide has shown significant weight reduction in Phase 2 trials (Jastreboff et al., 2023, NEJM) but carries no approved dosing protocol, and self-administration guidance from social media bypasses the clinical monitoring these trials required. Compounded retatrutide sourced outside a regulated telehealth pathway has no verified potency, sterility, or safety data.
  • The 1mg per 10 units rule on a 100-unit syringe is arithmetically correct when 10mg peptide is dissolved in exactly 1ml bacteriostatic water, but it is a convention not a regulated clinical standard.
  • Retatrutide is an investigational GLP-1/GIP/glucagon tri-agonist with no FDA or TGA approval. Phase 2 data published in NEJM (Jastreboff et al., 2023) showed up to 24.2% weight loss but under monitored trial conditions.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The 1mg per 10 units rule on a 100-unit syringe is arithmetically correct when 10mg peptide is dissolved in exactly 1ml bacteriostatic water, but it is a convention not a regulated clinical standard.
  • Retatrutide is an investigational GLP-1/GIP/glucagon tri-agonist with no FDA or TGA approval. Phase 2 data published in NEJM (Jastreboff et al., 2023) showed up to 24.2% weight loss but under monitored trial conditions.
  • Bacteriostatic water preserved with 0.9% benzyl alcohol typically maintains a reconstituted peptide for up to 28 days when refrigerated at 2-8 degrees Celsius. The video does not mention this storage window.
  • Gentle swirling is the correct reconstitution technique. Shaking can cause peptide aggregation and degradation, consistent with stability data in Manning et al. (2019, Journal of Pharmaceutical Sciences).
  • The video correctly distinguishes total peptide mass from post-reconstitution concentration, which is a meaningful educational point that reduces dosing errors.
  • No dose calculator replaces clinical oversight. Retatrutide and other GLP-1 class compounds carry risks including nausea, vomiting, elevated heart rate, and potential pancreatitis that require prescriber monitoring.
  • Compounded peptides sourced outside a regulated pharmacy or telehealth pathway have no verified potency or sterility. The math only works if the labeled peptide mass is accurate, which cannot be assumed from unregulated suppliers.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @ahleesahhh actually say?

The creator walked through how to reconstitute a lyophilized peptide, specifically using retatrutide as the example. The core advice: dissolve 10mg of peptide in exactly 1ml of bacteriostatic water. This produces, in her words, math that is "a whole lot easier" because on a 100-unit insulin syringe, each 10 units equals 1mg of peptide. She then demonstrated dose scaling, showing that 1mg requires drawing 10 units, 2mg requires 20 units, and 5mg requires 50 units. She also noted that some people use 3ml per vial but said this makes the calculation "a bit messy."

She was careful to distinguish between total peptide mass and dosing strength, saying "10mg is not the strength. It is the total amount of product in this vial." That distinction matters, and she made it clearly.

Does the science back this up?

The math itself is correct. The chemistry of reconstitution supports this approach, with some important caveats she did not address. Bacteriostatic water is the appropriate diluent for most research-grade lyophilized peptides, and the 1ml per 10mg ratio is a widely used convention. The linear scaling she demonstrated is arithmetically sound for a homogeneous solution.

What the science also tells us is that reconstitution technique matters beyond just ratios. A 2019 review by Manning et al. in the Journal of Pharmaceutical Sciences documented that agitation method, temperature, and pH of the diluent all affect peptide stability after reconstitution. Swirling gently, as she recommends rather than shaking, is consistent with standard handling guidance for fragile peptide bonds. However, no peer-reviewed literature specifically validates the 1ml per 10mg ratio as a clinical standard. It is a practical convention, not a regulated protocol.

What did they get right, and what's missing?

Credit where it is due: the instruction to add water at an angle and swirl rather than shake is correct. Vigorous shaking can introduce air bubbles and potentially denature peptides. The distinction she draws between total peptide mass and concentration is genuinely useful and frequently misunderstood by newcomers.

The gaps are significant though. She did not mention storage conditions after reconstitution. Most lyophilized peptides, once reconstituted in bacteriostatic water, should be refrigerated at 2-8 degrees Celsius and used within a defined window, typically 28 days according to standard compounding guidance. She also did not address the fact that retatrutide specifically is an investigational GLP-1/GIP/glucagon receptor tri-agonist with no approved dosing protocol outside clinical trials. Presenting dose escalation from 1mg to 5mg as routine weekly math glosses over the fact that this compound has only completed Phase 2 trials. Lilly's 2023 Phase 2 data published in the New England Journal of Medicine used doses up to 12mg weekly, but under monitored clinical conditions, not self-injection at home based on a TikTok calculator.

What should you actually know?

The reconstitution math tutorial is largely accurate as a mechanical exercise. But math accuracy does not equal safety. Several things this video does not tell you matter more than unit conversions.

  • Bacteriostatic water contains 0.9% benzyl alcohol as a preservative. People with benzyl alcohol sensitivity should not use it.
  • Reconstituted peptides are not sterile indefinitely. The 28-day refrigerated window for bacteriostatic water preparations is a compounding standard, not a conservative estimate.
  • Retatrutide is not approved by the FDA, TGA, or any other major regulatory body as of 2024. It is available only through compounding pharmacies or gray-market research chemical suppliers, and quality varies considerably.
  • Dosing decisions for any GLP-1 class compound, investigational or otherwise, should involve a prescribing clinician who can monitor for gastrointestinal side effects, heart rate changes, and pancreatitis risk.

The calculator she references may be useful for arithmetic, but no app accounts for individual pharmacokinetics, body weight, renal function, or drug interactions. A formula does not replace a prescriber.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Thatgirlahleesah🦋 · TikTok creator

142.3K views on this video

A little video to help anyone out with their maths #reconstituting #howtomixpeptides

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the 1mg per 10 units rule on a 100-unit syringe?

The 1mg per 10 units rule on a 100-unit syringe is arithmetically correct when 10mg peptide is dissolved in exactly 1ml bacteriostatic water, but it is a convention not a regulated clinical standard.

What does the video say about retatrutide?

Retatrutide is an investigational GLP-1/GIP/glucagon tri-agonist with no FDA or TGA approval. Phase 2 data published in NEJM (Jastreboff et al., 2023) showed up to 24.2% weight loss but under monitored trial conditions.

What does the video say about bacteriostatic water preserved with 0.9% benzyl alcohol typically maintains a?

Bacteriostatic water preserved with 0.9% benzyl alcohol typically maintains a reconstituted peptide for up to 28 days when refrigerated at 2-8 degrees Celsius. The video does not mention this storage window.

What does the video say about gentle swirling?

Gentle swirling is the correct reconstitution technique. Shaking can cause peptide aggregation and degradation, consistent with stability data in Manning et al. (2019, Journal of Pharmaceutical Sciences).

What does the video say about the video correctly distinguishes total peptide mass from post-reconstitution concentration,?

The video correctly distinguishes total peptide mass from post-reconstitution concentration, which is a meaningful educational point that reduces dosing errors.

What does the video say about no dose calculator replaces clinical oversight. retatrutide?

No dose calculator replaces clinical oversight. Retatrutide and other GLP-1 class compounds carry risks including nausea, vomiting, elevated heart rate, and potential pancreatitis that require prescriber monitoring.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Thatgirlahleesah🦋, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.